Oligopeptide-68 Powder Powder CAS 1206525-47-4

Oligopeptide-68 powder mimics the binding of TGF-β to cell surface receptors, specifically downregulating the expression of microphthalmia-associated transcription factor (MITF) genes, thereby blocking melanin production signaling at its source. MITF is a core transcription factor regulating key enzymes in melanin production, such as tyrosinase, TRP-1, and TRP-2; its inhibition can comprehensively reduce the pigment synthesis capacity of melanocytes.

Oligopeptide-68 is a dual-pathway whitening technology officially approved in Japan. It targets melanin production at the gene level, addressing both hereditary pigmentation and mitigating acquired factors like UV rays and inflammation. A concentration of 0.01% achieves three times the effect of traditional whitening agents with zero irritation risk, making it safe for sensitive skin. It not only helps you develop differentiated whitening products but also allows you to capture the two blue ocean markets of 'whitening for sensitive skin' and 'stubborn pigmentation,' bringing a premium of over 30%.

With its dual-pathway melanin-inhibiting mechanism, gene-level regulation, and high safety, Oligopeptide-68 is becoming a revolutionary ingredient in the whitening cosmetics industry. It not only solves the problem of hereditary pigmentation that traditional whitening agents struggle to address but also meets the whitening needs of sensitive skin, providing brands with a differentiated competitive advantage. As consumer demand for highly effective and safe whitening products grows, Oligopeptide-68 is expected to become a core ingredient in the high-end whitening market within the next 2-3 years, representing enormous market potential.